Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: Effects of the i f current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome-RIVIERA trial study design and rationale

1. Dominguez-Rodriguez, A.
2. Fard, S.S.
3. Abreu-Gonzalez, P.
4. Bosa-Ojeda, F.
5. Consuegra-Sanchez, L.
6. Jiménez-Sosa, A.
7. Grande, A.S.
8. Kaski, J.C.